Cannabis Company, Organigram, Reports An Impressive Q3 Turnaround
August 14, 2024 at 18:16 PM EDT
The Company is pleased with its positive adjusted EBITDA Q3 results and, with $173 million in pro-forma cash believes they have one of the strongest balance sheets in the industry and are well positioned to capitalize on future growth opportunities.
